https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-04-30 / Int. J. Mol. Med. 2013 Jul;32(1):195-202
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-04-30 / Int. J. Mol. Med. 2013 Jul;32(1):195-2022013-04-30 00:00:002019-02-15 09:17:14Identification of common gene networks responsive to mild hyperthermia in human cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-04-19 / Cancer Immunol. Immunother. 2013 Jun;62(6):1083-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-04-19 / Cancer Immunol. Immunother. 2013 Jun;62(6):1083-912013-04-19 00:00:002019-02-15 08:52:30Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-04-16 / Cancer Immunol. Immunother. 2013 May;62(5):909-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-04-16 / Cancer Immunol. Immunother. 2013 May;62(5):909-182013-04-16 00:00:002019-02-15 08:48:36Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-04-14 / Evid Based Complement Alternat Med 2013;2013:672873
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-04-14 / Evid Based Complement Alternat Med 2013;2013:6728732013-04-14 00:00:002019-02-15 09:17:13Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2013-04-12 17:22:322019-02-12 17:22:47Science kürt Immuntherapie gegen Krebs 2013 zum „Breakthrough of the Year“
